1. Home
  2. DOYU vs GNLX Comparison

DOYU vs GNLX Comparison

Compare DOYU & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DouYu International Holdings Limited ADS

DOYU

DouYu International Holdings Limited ADS

HOLD

Current Price

$4.74

Market Cap

129.8M

Sector

Technology

ML Signal

HOLD

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$2.48

Market Cap

110.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOYU
GNLX
Founded
2014
2001
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
129.8M
110.4M
IPO Year
2019
2022

Fundamental Metrics

Financial Performance
Metric
DOYU
GNLX
Price
$4.74
$2.48
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$7.00
★ $17.25
AVG Volume (30 Days)
26.7K
★ 266.4K
Earning Date
05-19-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 9.47
EPS
★ N/A
N/A
Revenue
N/A
★ $8,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.18
$2.29
52 Week High
$7.66
$8.54

Technical Indicators

Market Signals
Indicator
DOYU
GNLX
Relative Strength Index (RSI) 58.35 44.65
Support Level $4.37 $2.34
Resistance Level $4.88 $2.86
Average True Range (ATR) 0.15 0.14
MACD 0.02 0.01
Stochastic Oscillator 90.57 39.29

Price Performance

Historical Comparison
DOYU
GNLX

About DOYU DouYu International Holdings Limited ADS

DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company aims to build an integrated game-centric ecosystem of livestreaming, video, voice, graphic content, and other interactive and community features. The company operates the platform both on mobile apps and PC portals, through which users can enjoy immersive and interactive games and entertainment livestreaming, access a wide array of video and graphic content, and participate in community events and discussions.

About GNLX Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Share on Social Networks: